PackGene is a U.S.-based gene therapy CRO/CDMO with facilities in Texas, Massachusetts, China, and Switzerland. The company provides end-to-end development and manufacturing services for mRNA and AAV-based therapeutics and vaccines, including plasmid production, mRNA synthesis, LNP encapsulation, formulation development, aseptic fill/finish, viral vector manufacturing, and analytical testing. PackGene supports projects from early-stage R&D through preclinical development, IND studies, and commercial production, offering integrated solutions to accelerate cell and gene therapy programs.